Clinical Trial Update: Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine [Phase 4]

View source ↗

Summary

Phase 4 trial comparing intranasal fluticasone furoate to oral fexofenadine for seasonal allergic rhinitis; the study completed and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Fexofenadine (fexofenadine)
• Veramyst (fluticasone furoate nasal spray) (fluticasone furoate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Seasonal | Phase 4 | Status: COMPLETED | Results posted: 2018-02-05